1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Antiviral Drugs Market
4.
Executive Summary
5. Voice of Customer
6. Global Antiviral
Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Drug Class (DNA
Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors,
m-RNA Synthesis Inhibitors, Integrase Inhibitors, Others)
6.2.2. By Indication (Coronavirus
Infection, HIV, Hepatitis, Herpes Simplex Virus, Influenza, Others (Pneumonia,
Flu))
6.2.3. By Route of
Administration (Oral, Topical, Parenteral, Others)
6.2.4. By Type (Branded,
Generic)
6.2.5. By Age Group
(Pediatric, Adult, Geriatric)
6.2.6. By End-User
(Hospitals, Homecare, Specialty Clinics, Others)
6.2.7. By Distribution
Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
6.2.8. By Company (2021)
6.2.9. By
Region
6.3. Product
Market Map
7. Asia-Pacific Antiviral
Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Indication
7.2.3. By Route of
Administration
7.2.4. By Type
7.2.5. By Age Group
7.2.6. By End User
7.2.7. By Distribution
Channel
7.2.8.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Antiviral Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Class
7.3.1.2.2.
By Indication
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By Type
7.3.1.2.5.
By Age Group
7.3.1.2.6.
By End User
7.3.1.2.7.
By Distribution Channel
7.3.2.
India Antiviral Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By Indication
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By Type
7.3.2.2.5.
By Age Group
7.3.2.2.6.
By End User
7.3.2.2.7.
By Distribution Channel
7.3.3.
Japan Antiviral Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Class
7.3.3.2.2.
By Indication
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By Type
7.3.3.2.5.
By Age Group
7.3.3.2.6.
By End User
7.3.3.2.7.
By Distribution Channel
7.3.4.
South Korea Antiviral Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Class
7.3.4.2.2.
By Indication
7.3.4.2.3.
By Route of Administration
7.3.4.2.4.
By Type
7.3.4.2.5.
By Age Group
7.3.4.2.6.
By End User
7.3.4.2.7.
By Distribution Channel
7.3.5.
Australia Antiviral Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Class
7.3.5.2.2.
By Indication
7.3.5.2.3.
By Route of Administration
7.3.5.2.4.
By Type
7.3.5.2.5.
By Age Group
7.3.5.2.6.
By End User
7.3.5.2.7.
By Distribution Channel
8. Europe Antiviral
Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Indication
8.2.3. By Route of
Administration
8.2.4. By Type
8.2.5. By Age Group
8.2.6. By End User
8.2.7.
By Distribution Channel
8.2.8.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Antiviral Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Class
8.3.1.2.2.
By Indication
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By Type
8.3.1.2.5.
By Age Group
8.3.1.2.6.
By End User
8.3.1.2.7.
By Distribution Channel
8.3.2.
Germany Antiviral Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Class
8.3.2.2.2.
By Indication
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By Type
8.3.2.2.5.
By Age Group
8.3.2.2.6.
By End User
8.3.2.2.7.
By Distribution Channel
8.3.3.
United Kingdom Antiviral Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Class
8.3.3.2.2.
By Indication
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By Type
8.3.3.2.5.
By Age Group
8.3.3.2.6.
By End User
8.3.3.2.7.
By Distribution Channel
8.3.4.
Italy Antiviral Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Drug Class
8.3.4.2.2.
By Indication
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By Type
8.3.4.2.5.
By Age Group
8.3.4.2.6.
By End User
8.3.4.2.7.
By Distribution Channel
8.3.5.
Spain Antiviral Drugs Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Drug Class
8.3.5.2.2.
By Indication
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By Type
8.3.5.2.5.
By Age Group
8.3.5.2.6.
By End User
8.3.5.2.7.
By Distribution Channel
9. North America Antiviral
Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Indication
9.2.3. By Route of Administration
9.2.4. By Type
9.2.5. By Age Group
9.2.6. By End User
9.2.7.
By Distribution Channel
9.2.8.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Antiviral Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Class
9.3.1.2.2.
By Indication
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By Type
9.3.1.2.5.
By Age Group
9.3.1.2.6.
By End User
9.3.1.2.7.
By Distribution Channel
9.3.2.
Mexico Antiviral Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Class
9.3.2.2.2.
By Indication
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By Type
9.3.2.2.5.
By Age Group
9.3.2.2.6.
By End User
9.3.2.2.7.
By Distribution Channel
9.3.3.
Canada Antiviral Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Class
9.3.3.2.2.
By Indication
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By Type
9.3.3.2.5.
By Age Group
9.3.3.2.6.
By End User
9.3.3.2.7.
By Distribution Channel
10. South America Antiviral
Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Indication
10.2.3. By Route of
Administration
10.2.4. By Type
10.2.5. By Age Group
10.2.6. By End User
10.2.7.
By Distribution Channel
10.2.8.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Antiviral Drugs Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Drug Class
10.3.1.2.2.
By Indication
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By Type
10.3.1.2.5.
By Age Group
10.3.1.2.6.
By End User
10.3.1.2.7.
By Distribution Channel
10.3.2.
Argentina Antiviral Drugs Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Drug Class
10.3.2.2.2.
By Indication
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By Type
10.3.2.2.5.
By Age Group
10.3.2.2.6.
By End User
10.3.2.2.7.
By Distribution Channel
10.3.3.
Colombia Antiviral Drugs Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Drug Class
10.3.3.2.2.
By Indication
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By Type
10.3.3.2.5.
By Age Group
10.3.3.2.6.
By End User
10.3.3.2.7.
By Distribution Channel
11. Middle East and
Africa Antiviral Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1. By Drug Class
11.2.2. By Indication
11.2.3. By Route of
Administration
11.2.4. By Type
11.2.5. By Age Group
11.2.6. By End User
11.2.7.
By Distribution Channel
11.2.8.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Antiviral Drugs Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Drug Class
11.3.1.2.2.
By Indication
11.3.1.2.3.
By Route of Administration
11.3.1.2.4.
By Type
11.3.1.2.5.
By Age Group
11.3.1.2.6.
By End User
11.3.1.2.7.
By Distribution Channel
11.3.2.
Saudi Arabia Antiviral Drugs Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Drug Class
11.3.2.2.2.
By Indication
11.3.2.2.3.
By Route of Administration
11.3.2.2.4.
By Type
11.3.2.2.5.
By Age Group
11.3.2.2.6.
By End User
11.3.2.2.7.
By Distribution Channel
11.3.3.
UAE Antiviral Drugs Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Drug Class
11.3.3.2.2.
By Indication
11.3.3.2.3.
By Route of Administration
11.3.3.2.4.
By Type
11.3.3.2.5.
By Age Group
11.3.3.2.6.
By End User
11.3.3.2.7.
By Distribution Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape
14.1.
Competition Outlook
14.2.
Players Profiled
14.2.1.
Merck & Co. Inc.
14.2.2.
F. Hoffmann-La Roche
Ltd.
14.2.3.
Johnson &
Johnson Services, Inc.
14.2.4.
GlaxoSmithKline PLC
14.2.5.
Mylan N.V.
14.2.6.
Cipla Ltd.
14.2.7.
Laurus Labs Ltd.
14.2.8.
Micro Labs Ltd.
14.2.9.
Gilead Sciences,
Inc.
14.2.10.
Sun Pharmaceutical
Industries Ltd.
14.2.11.
Amneal
Pharmaceuticals LLC
14.2.12.
Alembic
Pharmaceuticals Limited
14.2.13.
Novartis AG
14.2.14.
Bristol Myers Squibb
Company
14.2.15.
AstraZeneca Ltd.
15.
Strategic Recommendations